Zeven (dalbavancin) / RaQualia, AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zeven (dalbavancin) / RaQualia, AbbVie
NCT00678106: Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections

Completed
1
10
US
Dalbavancin
Pfizer
Bacterial Infections
07/09
07/09
NCT01946568 / 2013-003227-11: A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.

Completed
1
36
US, Europe
Dalbavancin
Durata Therapeutics Inc., an affiliate of Allergan plc
Bacterial Infections.
04/15
04/15
NCT02688790: Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

Terminated
1
8
US
Dalbavancin, Dalvance®
AbbVie
Bacterial Infections
04/19
04/19
NCT03617042 / 2022-000415-32: Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

Recruiting
1
22
US
Dalbavancin, Dalvance®
Allergan, Allergan
Bacterial Infections
10/19
10/19
NCT06810583: A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

Recruiting
1
29
US
Dalbavancin, Fluoroquinolone (either ciprofloxacin or levofloxacin at the discretion of the treating clinician)
St. Jude Children's Research Hospital
Leukemia, Acute Myeloid Leukemia, Lymphoblastic Leukemia in Children
09/28
09/30

Download Options